Radar · Genomics in San Diego
Best Genomics Companies in San Diego, United States
The 180 best Genomics companies in San Diego, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Human Longevity.
By Riya SenguptaFinancials
180companies tracked
$6.3Bdisclosed funding
0unicorns
114have raised
FLIAR INTELLIGENCE · GENOMICS × SAN DIEGO
Our analysis of 50 Genomics companies
$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
50companies analysed
84%cloud-native stacks
2025funding peak (by rounds)
2unicorns
2016median founding year
5.3Mcombined LinkedIn audience
97%of audience held by top 3
4companies hiring publicly (12 mo)
Ranked: Best Genomics companies in San Diego
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Human Longevity Provider of precision medicine, preventative health assessments, and longevity care | $409M | 21 mo ago | 85 | J Venter Co-Founder & CEO | TurbopackNode.jsYouTube+23 | Top 5M | 71 patents AI-driven multi‑omic analytics for disease risk assessment, diagnosis, and genomic trait prediction | 1 launch · 1 partnership |
| 2 | Singlera Genomics Developer of next generation sequencing by methylation haplotyping approach for the detection of cancer | $380M | 66 mo ago | 18 | Yuan Gao Co-Founder & Chairman | — | — | 32 patents Patents concentrated in chemistry & materials | — |
| 3 | Ambrx Developer of Antibody drug conjugates to treat cancers, metabolic disorders and cardiovascular disorders | $346M | 67 mo ago | 79 | Lawson Macartney President & Ceo | WordPressBugHerdMySQL+26 | Top 10M | 1,276 patents Protein engineering and antibody-drug conjugates for therapeutic biologics | — |
| 4 | Poseida Therapeutics Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | $324M | 34 mo ago | 259 | — | WordPressMySQLPHP+18 | Top 10M | 426 patents Patents concentrated in chemistry & materials | — |
| 5 | ADARx Pharmaceuticals Developer of genetic therapeutic solutions to edit single point mutations on RNA transcripts | $286M | 34 mo ago | 44 44 → 95 (+116%) | Zhen Li Co-Founder & CEO | — | — | 152 patents RNA‑based therapeutics and enzyme modulation for neurodegenerative disease treatment | 5 job openings |
| 6 | Aspen Neuroscience Provider of genomic-based personalised pluripotent stem cell therapy 64Funding top 17%Patents top 23%Moat top 28%Innovation top 33% All 10 signals ▾Fundingtop 17% Patentstop 23% Moattop 28% Innovationtop 33% Growthtop 35% Newstop 45% Marketbottom 49% Talentbottom 49% Techbottom 46% Globalbottom 45% Funding: Raised $224M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) Patents: 57 patents matched (strict assignee match) · 51 filings since 2022 vs 6 in 2017-21 rank vs industry peers · Fliar Intelligence Index 64/100 | $224M | 6 mo ago | 94 | Damien Mcdevitt President | WordPress Block EditorWordPressMySQL+19 | Top 10M | 57 patents Patents concentrated in computing, sensing & instrumentation | — |
| 7 | Biora Therapeutics Provider of non invasive prenatal genomic testing | $217M | 61 mo ago | 125 | Harry Stylli CEO and Chairman of the Board | — | — | — | — |
| 8 | Astute Medical Pioneering diagnostics to improve global health through innovative solutions | $207M | 114 mo ago | 51 | — | — | — | 769 patents Renal injury biomarkers and diagnostic/therapeutic assays for acute kidney disease | 1 launch · 1 award |
| 9 | Epic Sciences Provider of non-invasive tests for the detection of circulating tumor cells | $204M | 38 mo ago | 98 | — | — | — | 145 patents Liquid biopsy technologies for detecting and profiling circulating tumor cells in cancer. | — |
| 10 | Millenium Health Systems Drug testing laboratory empowering clinicians with comprehensive data insights for patient care | $196M | 190 mo ago | 484 | — | WordPressApple iCloud MailMySQL+24 | Top 5M | — | — |
| 11 | Turnstone Biologics Developer of oncolytic viral immunotherapies for cancer treatment | $172M | 59 mo ago | 80 | John Bell Co-Founder | WordPress Block EditorWordPressApple iCloud Mail+19 | Top 50M | 61 patents Engineered tumor-infiltrating lymphocytes and ex vivo T‑cell expansion for cancer immunotherapy | — |
| 12 | Denovo Biopharma Developer of genomic biomarker discovery platform | $172M | 66 mo ago | 42 42 → 28 (-33%) | — | — | — | 50 patents Predictive biomarkers and assays for nucleic‑acid therapeutics and neuro‑transporter drug efficacy | — |
| 13 | Omniome Provider of genome sequencing platform | $160M | 78 mo ago | 164 | — | — | — | 267 patents High-throughput nucleic acid sequencing, analysis, and engineered polymerase technologies | — |
| 14 | Locana Developer of CRISPR enabled RNA editing for gene therapy | $155M | 37 mo ago | 68 | Jeffrey Ostrove -CEO & Director | — | — | 11 patents RNA-targeted CRISPR/Cas fusion therapeutics for gene knockdown, replacement, and immunomodulation | — |
| 15 | Mirati Therapeutics Developer of therapeutic solutions for the treatment of cancer | $153M | 129 mo ago | 587 | — | — | — | 713 patents Targeted small‑molecule inhibitors and combos for KRAS‑mutant and related oncogenic pathways | — |
| 16 | Expansion Therapeutics Provider of a software system for the development of drugs | $140M | 56 mo ago | 20 | Matthew Disney Co-Founder | — | — | — | — |
| 17 | OmeCare Provider of genetic testing kits for fitness, and nutrition management | $130M | 125 mo ago | 22 | — | — | — | — | — |
| 18 | Bionano Provider of genome analysis solutions to researchers and clinicians | $124M | 24 mo ago | 364 | Erik Holmlin President & CEO | WordPressMySQLPHP+25 | Top 5M | 43 patents Iron‑based nanomaterials and nanoemulsion formulations for pharmaceutical delivery | — |
| 19 | Tocagen Developer of gene therapies for the treatment of cancer | $124M | 105 mo ago | 1 | — | — | — | 161 patents Gene therapy and CAR‑T delivery vectors with cytosine deaminase prodrug activation | — |
| 20 | DTx Pharma Provider of RNA-based therapeutics for multiple health purposes | $113M | 63 mo ago | 50 | — | — | — | — | — |
| 21 | Ignyta Personalized medicine for cancer and autoimmune diseases | $97M | 104 mo ago | 30 | Gary Firestein Co-Founder | — | — | 240 patents Small‑molecule kinase inhibitors for oncology, notably entrectinib and related cancer drugs | — |
| 22 | AltheaDx Molecular biomarker discovery, assay development and validation, clinical trial testing and companion… | $95M | 66 mo ago | 12 | — | — | — | 6 patents Molecular diagnostics and bioinformatics for gene expression, degraded nucleic acids, and single‑cell profiling | — |
| 23 | Sequenom Provider of noninvasive prenatal testing using circulating cell-free fetal nucleic acids | $85M | 132 mo ago | 524 | — | — | — | 1,144 patents Non‑invasive prenatal cfDNA testing for fetal genetic and chromosomal abnormalities | — |
| 24 | Synthorx Provider of solutions for drug discovery, diagnostics, and vaccines using a synthetic DNA base pair | $79M | 97 mo ago | 50 | Floyd Romesberg Founder | — | — | 299 patents Engineered cytokine conjugates and synthetic biology tools for therapeutic protein production | — |
| 25 | Molecular Assemblies Provider of an enzymatic DNA synthesis product for researchers | $78M | 51 mo ago | 21 | — | — | — | 91 patents Automated synthesis of DNA/RNA using reusable initiators and engineered enzymes | — |
| 26 | PetDx Developer of liquid biopsy technology for detection of cancer in dogs | $72M | 57 mo ago | 102 | Daniel Grosu Co-Founder & CEO | — | — | 11 patents Liquid biopsy fragmentomics for cancer detection and monitoring, including mitochondrial DNA analysis | — |
| 27 | ClearNote Health Developer of non-invasive cancer detection methods 40Moat top 22%Funding top 36%Market top 50%Talent bottom 49% All 5 signals ▾Moattop 22% Fundingtop 36% Markettop 50% Talentbottom 49% Globalbottom 36% Moat: Editorial + unicorn rating 8/10 · Soonicorn Funding: Raised $70.0M across 2 rounds · 2 rounds over 5 yrs (0.4/yr) rank vs industry peers · Fliar Intelligence Index 40/100 | $70M | 0 mo ago | 45 | Dave Mullarkey Chief Executive Officer | — | — | — | — |
| 28 | GenomeDx Biosciences Genomic tests for urologic cancers | $70M | 73 mo ago | 159 | — | — | — | — | — |
| 29 | OncoSec Medical Developer of intratumoral immunotherapies to harness the body's immune system to fight cancer | $69M | 90 mo ago | 26 | — | — | — | 148 patents Cancer immunotherapy response biomarkers and electroporation-based gene delivery technologies. | — |
| 30 | Biological Dynamics Provider of molecular diagnostics plaform | $68M | 67 mo ago | 54 | — | Cart FunctionalitySquarespace CommerceSquarespace+20 | Top 50M | 78 patents Biomedical diagnostics and biomarker detection, analyte data processing, dielectric materials, surface functionalization | — |
| 31 | Biocept Developer of personalized cancer diagnosis through liquid biopsy | $59M | 106 mo ago | 165 | — | — | — | 208 patents Liquid biopsy technologies for circulating tumor cell capture and nucleic acid analysis. | — |
| 32 | Actio Biosciences Developer of genetics-led therapies targeting shared biology between rare, common diseases | $55M | 12 mo ago | 21 | David Goldstein Co-Founder & CEO | WordPress Block EditorWordPressMySQL+9 | Top 10M | — | 1 job opening |
| 33 | Replay Provider of genomic reprogramming platform for writing and delivering big DNA | $55M | 42 mo ago | 13 13 → 30 (+131%) | Ron Weiss Co-Founder | ContentfulApple iCloud MailMicrosoft 365+13 | Top 50M | 46 patents Patents concentrated in chemistry & materials | — |
| 34 | 1859 Provider of DNA encoded libraries for drug discovery and development | $50M | 55 mo ago | 73 | Devon Cayer Co-Founder & CEO | — | — | 30 patents High-throughput microfluidic bioassay platforms for drug and biomolecule screening | — |
| 35 | Electronic Bio Provider of nanotech-based DNA sequencing solutions 10Funding top 37%Talent bottom 45%Global bottom 29%Market bottom 24% All 5 signals ▾Fundingtop 37% Talentbottom 45% Globalbottom 29% Marketbottom 24% Techbottom 15% Funding: Raised $40.7M across 49 rounds · 49 rounds over 19 yrs (2.6/yr) Talent: 1 named leader on record rank vs industry peers · Fliar Intelligence Index 10/100 | $41M | 12 mo ago | 15 | Eric Ervin President and CEO | — | — | — | — |
| 36 | VedaBio Provider of molecular detection and editing platform using CRISPR Cascade technology | $40M | 32 mo ago | — | Anurup Ganguli Co-Founder & CEO | WebflowThree.jsSwiper+12 | Top 50M | 63 patents Design and delivery of engineered nucleic‑acid cascade circuits for therapeutic and diagnostic applications | — |
| 37 | Regulus Therapeutics Innovative medicines company reimagining medicine to improve and extend people’s lives | $35M | 27 mo ago | 30 | — | WordPressMySQLPHP+11 | Top 5M | 403 patents Antisense oligonucleotide therapeutics for polycystic kidney disease and neurological disorders | — |
| 38 | Zafrens Provider of single-cell multi-omics analysis platform for researchers | $29M | 16 mo ago | 19 19 → 30 (+58%) | Yi Zhang Co-Founder & EVP of Engineering | — | — | 6 patents Patents concentrated in computing, sensing & instrumentation | — |
| 39 | TriLink BioTech Developer of nucleic acid and mRNA products for research applications | $29M | 15 mo ago | 348 | — | Cart FunctionalityMagentoApple iCloud Mail+38 | Top 5M | — | 3 launchs · 1 expansion · 1 award |
| 40 | Function Oncology Developer of therapeutics to treat cancer | $28M | 38 mo ago | 16 | Christian Schmedt Co-Founder | — | — | 9 patents Functional genomic profiling of cancers using CRISPR-based personalized screening | — |
| 41 | Telesis Bio Online platform offering life sciences reagents and kits | $25M | 36 mo ago | 125 | Todd Nelson CEO | WordPressApple iCloud MailMySQL+29 | Top 10M | — | 1 job opening · 3 launchs |
| 42 | Rejuvenate Bio Developer of gene therapies for treating chronic and age-related diseases | $15M | 23 mo ago | 39 | Noah Davidsohn Co-Founder & CSO | Cart FunctionalitySquarespace CommerceSquarespace+12 | Top 10M | — | — |
| 43 | Navega Therapeutics Developer of gene therapy products for chronic pain management | $15M | 13 mo ago | 10 | Prashant Mali Co-Founder | — | — | — | — |
| 44 | Eclipse Bio Developer of cell-free immunoassay | $14M | 7 mo ago | 14 | Eric Van Nostrand Co-Founder | WordPressMySQLMariaDB+25 | Top 10M | — | 1 award |
| 45 | CRISPR QC Provider of real-time CRISPR gene editing analysis. It offers solutions for measuring RNP formation, DNA… | $12M | 29 mo ago | 12 | Ross Bundy Chief Executive Officer | WordPressMySQLPHP+21 | Top 50M | — | — |
| 46 | Alida Biosciences Provider of technology for RNA analysis to improve human health | $12M | 15 mo ago | 16 | Byron Purse Co-Founder | Cart FunctionalityWooCommerceWordPress+24 | Top 10M | — | 1 internship |
| 47 | Visgenx Developer of gene therapy for age related muscular degeneration | $9M | 36 mo ago | 9 | Marty Emanuele Co-Founder & CSO | — | — | 16 patents ELOVL2-based gene therapy vectors for treating ocular diseases | — |
| 48 | Renova Therapeutics Developer of gene therapies for congestive heart failure and type 2 diabetes | $8M | 22 mo ago | 7 | Jack Reich Chief Executive Officer | WordPressMySQLPHP+17 | Top 50M | — | — |
| 49 | Arima Genomics Developer of technologies for genome sequence and structure | $7M | 11 mo ago | 48 | — | WordPressMySQLPHP+31 | Top 10M | 29 patents Patents concentrated in chemistry & materials | 1 partnership · 1 award |
| 50 | Defined Bioscience Developer of cell culture reagents, growth medium, and kits for cell-based assays | $2M | 14 mo ago | 6 | Steven Rees Founder & CEO | Cart FunctionalityShopifyShop Pay+17 | Top 10M | — | 1 partnership |
Top 12 Genomics companies in San Diego
#1
Series D · San Diego, California · founded 2016 · 45 employees$70Mraised▾
Series D · San Diego, California · founded 2016 · 45 employees
Developer of non-invasive cancer detection methods. It offers a 5-hydroxymethylcytosine-based epigenomic platform and cell-free DNA-based assays to measure biological changes in cells and detect cancers with high mortality rates when they respond best to treatment.
Fliar Intelligence Index™ 40how this company ranks against its industry peers
Moat
top 22%Funding
top 36%Market
top 50%Talent
bottom 49%Global
bottom 36%Moat: Editorial + unicorn rating 8/10 · Soonicorn
Funding: Raised $70.0M across 2 rounds · 2 rounds over 5 yrs (0.4/yr) · Last round Series D (May 2026)
Market: 45 employees (top 39% of Life Sciences)
Audience (LinkedIn): 6k LinkedIn followers
Funding rounds
- May 2025Series C$21.8M
- May 2021Series C$70M
Founders & team
Investors
Pathology Asia Holdings
#2
Series C · San Diego, California · founded 2018 · 94 employees$224Mraised▾
Series C · San Diego, California · founded 2018 · 94 employees
Provider of genomic-based personalized pluripotent stem cell therapy. It offers regenerative cell treatment like dopaminergic neurons for Parkinson's disease and other neurological disorders. It maintains the genetic-based quality control to avoid the mutation of cells used for therapy.
Fliar Intelligence Index™ 64how this company ranks against its industry peers
Funding
top 17%Patents
top 23%Moat
top 28%Innovation
top 33%Growth
top 35%News
top 45%Funding: Raised $224M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) · Last round Series C (Nov 2025)
Patents: 57 patents matched (strict assignee match) · 51 filings since 2022 vs 6 in 2017-21 · Latest publication 2026
Moat: Editorial + unicorn rating 8/10 · IP moat: 57 patents · Soonicorn
Audience (LinkedIn): 13k LinkedIn followers
Funding rounds
- Nov 2025Series C$115M
- Dec 2022Conventional Debt$40M
- May 2022Series B$147.5M
- Apr 2020Series A$70M
Founders & team
Investors
Orbimed, Arch Venture Partners, Frazier Healthcare Partners, Domain Associates, S32, Google Ventures
Tech stack
CloudflareCloudflare Bot ManagementCore-JsGeneratepressGeneratepress Gp PremiumGodaddy
#3
Series B · San Diego, California · founded 2013 · 85 employees$408.7Mraised▾
Series B · San Diego, California · founded 2013 · 85 employees
Provider of precision medicine, preventative health assessments, and longevity care. The company offers comprehensive health assessments to detect life-threatening conditions early. It focuses on data-driven, personalized healthcare designed to uncover health risks. The company provides services to help individuals take control of their health.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 31k LinkedIn followers
Activity: 1 product launches · 1 partnerships (incl. GlycanAge) announced in 12 mo
Funding rounds
- Aug 2024Series B$39.8M
- Mar 2023Series B$32M
- Oct 2022Series B$6.9M
- Jul 2019Series B$30M
Founders & team
Investors
Emerging Technology Partners, Threshold, OS Fund, Synthetic Genomics, Celgene, Illumina
Tech stack
Amazon CloudfrontAmazon S3Amazon Web ServicesApache Http ServerCloudflareCloudflare Bot Management
#4
Series A · San Diego, California · founded 2017 · 14 employees$14Mraised▾
Series A · San Diego, California · founded 2017 · 14 employees
Developer of cell-free immunoassay. The company have developed an eCLIP-seq method (high-throughput sequencing) which increases crosslinking and immunoprecipitation. It helps to identify RNA binding protein targets. The main components of each eCLIP include cancer cell line (HEK293T, K562), stem cells (human iPSC), differentiated stem cells (neurons, cardiomyocytes), and tissues (brain, heart).
LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers
Activity: 1 awards announced in 12 mo
Funding rounds
- Nov 2025Series A$4.9M
- Apr 2025Grant (prize money)$1.4M
- Jan 2025Grant (prize money)$1.4M
- Jul 2024Grant (prize money)$1.4M
Founders & team
Investors
Alexandria, Phoenix Venture Partners, IGlobe Partners, HHS
#5
Series B · San Diego, California · founded 2021 · 21 employees$55Mraised▾
Series B · San Diego, California · founded 2021 · 21 employees
Developer of genetics-led therapies targeting shared biology between rare, common diseases. It applies expertise in genetics, drug discovery, and data sciences. The focus is on pinpointing targets that cause rare diseases. The aim is to enhance understanding of both the target and disease. The approach guides therapeutic expansion to more prevalent diseases.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Hiring: 3 hiring posts in 12 mo (public) · momentum -1 · hiring: Program Team Lead (PTL), Sr. Dir/VP, Clinical Development
Funding rounds
- Jun 2025Series B$66M
- Sep 2023Series A$55M
Founders & team
Investors
Canaan, Droia Ventures, Deerfield, EcoR1, Euclidean, Euclidean Capital
Tech stack
CookieyesCore-JsFlywheelGodaddyLazysizesMysql
#6
Funding Raised · San Diego, California · founded 2002 · 15 employees$40.7Mraised▾
Funding Raised · San Diego, California · founded 2002 · 15 employees
Provider of nanotech-based DNA sequencing solutions. It offers systems for ion channel characterization, and chemical sensing and develops systems for nanopore and ion channel measurements. The instruments developed by the company aids with applications in DNA sequencing, ion channel characterization, and chemical sensing.
Fliar Intelligence Index™ 10how this company ranks against its industry peers
Funding
top 37%Talent
bottom 45%Global
bottom 29%Market
bottom 24%Tech
bottom 15%Funding: Raised $40.7M across 49 rounds · 49 rounds over 19 yrs (2.6/yr) · Last round Grant (prize money) (May 2025)
Talent: 1 named leader on record
Global: Single-market focus (United States)
Funding rounds
- May 2025Grant (prize money)$400K
- May 2025Grant (prize money)$350K
- Apr 2025Grant (prize money)$350K
- Mar 2025Grant (prize money)$386.5K
Founders & team
Investors
HHS, National Science Foundation, America’s Seed Fund
Tech stack
PhpUbuntuApache Http Server
#7
Acquired · San Diego, California · founded 1996 · 348 employees$28.7Mraised▾
Acquired · San Diego, California · founded 1996 · 348 employees
Develoeper of nucleic acid and mRNA products for research applications. The company offers a comprehensive product catalog focused on nucleic acids, mRNA reagents, and related tools for research, diagnostics, and therapeutics. It categories include nucleoside triphosphates (NTPs), modified nucleotides, capping analogs, enzymes, and kits.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 19k LinkedIn followers
Activity: 3 product launches · 1 awards · 1 expansions announced in 12 mo
Funding rounds
- Mar 2025Grant (prize money)$12.7M
- Mar 2025Grant (prize money)$12.7M
- Jan 2015Grant (prize money)$132.8K
- Feb 2013Grant (prize money)$132.8K
Investors
HHS
Tech stack
Adobe Client Data LayerAmazon S3Amazon Web ServicesAnimate.CssApple Icloud MailBootstrap
#8
Funding Raised · San Diego, California · founded 2018 · 10 employees$14.5Mraised▾
Funding Raised · San Diego, California · founded 2018 · 10 employees
Developer of gene therapy products for chronic pain management. The company's novel gene therapy platform to target and imitate the patients with a mutation in the genome where no pain is felt., and apply it to treat pain.
Funding rounds
- Apr 2025Grant (prize money)$4.3M
- Apr 2025Grant (prize money)$4.3M
- Apr 2025Grant (prize money)$2.2M
- Sep 2023Grant (prize money)$400K
Founders & team
Investors
HHS
#9
Series C · San Diego, California · founded 2015 · 48 employees$7Mraised▾
Series C · San Diego, California · founded 2015 · 48 employees
Developer of technologies for genome sequence and structure. Arima Genomics is developing a novel method of DNA sequencing that enables genome-scale phasing or haplotyping of DNA variants using a combination of proximity ligation (Hi-C), short-read DNA sequencing, and a proprietary probabilistic algorithm for haplotype assembly. The company calls its new method, HaploSeq, and is derived from work done by Selvaraj et al (Nature Biotechnology, 2013, Vol 31, pp-1111). The method addresses a currently unmet need for cost-effective and reliable methods for the phasing of variants. Arima has multiple SIBR grants from the Department of Health and human services to develop their method.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 12k LinkedIn followers
Activity: 1 partnerships · 1 awards (incl. Active Motif) announced in 12 mo
Funding rounds
- Jun 2025Series C$22M
- Feb 2023Grant (prize money)$2.1M
- Mar 2022Series B$7M
- Sep 2021Grant (prize money)$2.1M
Investors
Agilent, Co-win Ventures, Vectr Ventures, Berkeley Catalyst Fund, Tech Coast Angels, Ladder Ventures
Tech stack
AdrollAdroll Cmp SystemAutoptimizeCloudflareCloudflare Bot ManagementCore-Js
#10
Series A · San Diego, California · founded 2021 · 19 employees$29.2Mraised▾
Series A · San Diego, California · founded 2021 · 19 employees
Provider of single-cell multi-omics analysis platform for researchers. The company specializes in building tools and generating insights at the interface of biology, chemistry, and engineering. It offers multi-omic assays and the study of mechanistic insights into the RNA regulatory layer.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers
Activity: 1 product launches · 1 partnerships (incl. Z-ScreenTM) announced in 12 mo
Funding rounds
- Feb 2025Series A—
- Dec 2023Series A$23M
- Jan 2022Series A$6.2M
Founders & team
Investors
Prime Movers Lab, BlueYard, KOFA Healthcare Investments, Global Brain, FoundersX Ventures, Alix Ventures
#11
Series A · San Diego, California · founded 2020 · 16 employees$11.5Mraised▾
Series A · San Diego, California · founded 2020 · 16 employees
Provider of technology for RNA analysis to improve human health. The company offers new technologies in RNA biology to develop new medical treatments and diagnostic assays.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Funding rounds
- Mar 2025Grant (prize money)$1.7M
- Jun 2024Series A$7.5M
- May 2023Grant (prize money)$1.4M
- Jul 2022Grant (prize money)$259.6K
Founders & team
Investors
Genoa Ventures, FusionX Ventures, Vertical Venture Partners, HHS
Tech stack
Cart FunctionalityCloudflareCloudflare Bot ManagementCookieyesCore-JsFormidable Form
#12
Public · San Diego, California · founded 2002 · 364 employees$124.2Mraised▾
Public · San Diego, California · founded 2002 · 364 employees
Provider of genome analysis solutions to researchers and clinicians. It offers Saphyr system that uses a non-sequencing based optical mapping technology to analyse extremely long strands of genomic DNA. It is used for detecting genomic variants missed by next-generation sequencing (NGS) technologies and conventional cytogenetic techniques.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 31k LinkedIn followers
Funding rounds
- May 2024Post IPO$20M
- Mar 2019Post IPO$2.5M
- Dec 2014Series C$68.4M
- Jun 2014Series B$5M
Founders & team
Investors
NIH, NHGRI, Domain Associates, Battelle Ventures, KT Venture Group, 21Ventures
Tech stack
Amazon SesAmazon Web ServicesCloudflareCloudflare Bot ManagementDocusignFancybox
Funding & investor landscape
$6.3Btotal disclosed funding
110companies funded
523disclosed rounds
0rounds last 90 days
Most active investors
Notable founders
Dave Mullarkey
Chief Executive Officer · ClearNote Health
Damien Mcdevitt
President · Aspen Neuroscience
J Venter
Co-Founder & CEO · Human Longevity
Peter Diamandis
Co-Founder · Human Longevity
Eric Van Nostrand
Co-Founder · Eclipse Bio
Gene Yeo
Co-Founder · Eclipse Bio
David Goldstein
Co-Founder & CEO · Actio Biosciences
Eric Ervin
President and CEO · Electronic Bio
Prashant Mali
Co-Founder · Navega Therapeutics
Ana Moreno
Co-Founder & CEO · Navega Therapeutics
Yi Zhang
Co-Founder & EVP of Engineering · Zafrens
Kandaswamy Vijayan
CEO · Zafrens
Prism market signals · United States · country-scoped Prism corpus, 1,273,702 docs
Market landscape — 10 sub-themes by coverage
Share of Genomics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH SIGNALS · United States
How research on Bioinformatics is moving in the United States
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 13,110 United States-affiliated papers.
research sentiment over time
200820182029
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and intensifying — the enthusiastic (strongly-positive) share moved 41% → 46% across 2008–2029.
top research entities
- Harvard University633
- Broad Institute433
- Howard Hughes Medical Institute318
- Stanford University287
- Johns Hopkins University287
leading researchers
Glen Charles Ritschel · Claude · Stylianos Chatzimanolis · Giannis Bolanakis · TARIK DEDOVIC · KATH-RYN ANN F. HANKINS · Christoforos Pavlou · Yue Ma
▲
Breakthroughs5,029 · 38%
▼ 39%→38% share
▲1.0× share momentum0 median citations85% since 2021mostly methods-led
Transcriptome breakthroughs are surging — U.S. papers rose from 25 to 436, with interpretability and pattern recognition newly emerging.
rising sub-themes (early→recent)
- Gene83→532
- Transcriptome25→436
- Genome117→419
- Disease6→218
- Immune system11→219
Newly emergingPattern recognition (psychology) 0→57 · Interpretability 0→50 · Limiting 0→47
Landmark Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 · 97,164 cites
◆
Advancements3,749 · 29%
▲ 21%→30% share
▲1.4× share momentum0 median citations90% since 2021mostly empirical
Biomarker advancement research is intensifying — papers jumped from 2 to 208, alongside newly emerging precision medicine work (86 papers).
rising sub-themes (early→recent)
- Disease17→407
- Immune system4→266
- Gene38→281
- Transcriptome13→238
- Biomarker2→208
Newly emergingPrecision medicine 0→86 · Pathogenesis 0→49 · Receptor 0→42
Landmark limma powers differential expression analyses for RNA-sequencing and microarray studies · 41,828 cites
▼
Concerns2,105 · 16%
▼ 18%→16% share
▼0.9× share momentum0 median citations85% since 2021mostly reviews
Disease-related concerns are escalating — U.S. papers grew from 27 to 311, with immunotherapy concerns newly emerging at 56 papers.
rising sub-themes (early→recent)
- Disease27→311
- Immune system6→152
- Cancer17→130
- Clinical trial4→111
- Biomarker2→92
Newly emergingImmunotherapy 0→56 · Narrative review 0→36 · Mutation 0→33
Landmark The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia · 10,090 cites
RESEARCH HOTSPOTS · United States
Where bioinformatics is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Boston1143 · +0.51
New York807 · +0.46
SF Bay Area683 · +0.57
Philadelphia330 · +0.44
San Diego298 · +0.56
Los Angeles287 · +0.42
Chicago284 · +0.51
Seattle244 · +0.54
Ann Arbor218 · +0.45
Atlanta215 · +0.44
PATENT SIGNAL · United States
Who's filing bioinformatics patents in the United States
United States bioinformatics patent filing is accelerating — 246 filings from 64 assignees (2016–2025), led by Edico Genome, Illumina, UNIV Washington; annual filings 22→23.
246 filings64 assigneespeak 44/yr2016–2025
filing momentum (YoY 2016–2025)
top patent filers
- Edico Genome129
- Illumina60
- UNIV Washington18
- Nantomics9
- Baluch Mohamed Khoso7
- Genomsys7
- Microsoft6
- Contamination Source Identificat5
Common questions
How many Genomics companies are there in San Diego, United States?
Radar tracks 180 indexable Genomics companies headquartered in San Diego, United States that meet our profile-completeness bar.
What is the total funding raised by Genomics companies in San Diego, United States?
The Genomics companies in San Diego, United States on this list have raised a combined $6.3B in disclosed equity funding across 110 funded companies.
Which is the highest-funded Genomics company in San Diego, United States?
Human Longevity is the highest-funded Genomics company in San Diego, United States, with $408.7M in disclosed equity funding.
How many Genomics companies in San Diego, United States are funded?
110 of the 180 Genomics companies in San Diego, United States on this list have disclosed at least one equity funding round.
How many Genomics unicorns are there in San Diego, United States?
None of the Genomics companies in San Diego, United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in San Diego, United States Genomics companies?
The most active investors in San Diego, United States Genomics companies on this list include HHS, Domain Associates, JLABS, Alexandria, Orbimed.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.